These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 20797415)
1. Microbial production of virus-like particle vaccine protein at gram-per-litre levels. Liew MW; Rajendran A; Middelberg AP J Biotechnol; 2010 Oct; 150(2):224-31. PubMed ID: 20797415 [TBL] [Abstract][Full Text] [Related]
2. A microbial platform for rapid and low-cost virus-like particle and capsomere vaccines. Middelberg AP; Rivera-Hernandez T; Wibowo N; Lua LH; Fan Y; Magor G; Chang C; Chuan YP; Good MF; Batzloff MR Vaccine; 2011 Sep; 29(41):7154-62. PubMed ID: 21651936 [TBL] [Abstract][Full Text] [Related]
3. High-throughput process development of an alternative platform for the production of virus-like particles in Escherichia coli. Ladd Effio C; Baumann P; Weigel C; Vormittag P; Middelberg A; Hubbuch J J Biotechnol; 2016 Feb; 219():7-19. PubMed ID: 26707548 [TBL] [Abstract][Full Text] [Related]
4. Integrated molecular and bioprocess engineering for bacterially produced immunogenic modular virus-like particle vaccine displaying 18 kDa rotavirus antigen. Tekewe A; Fan Y; Tan E; Middelberg AP; Lua LH Biotechnol Bioeng; 2017 Feb; 114(2):397-406. PubMed ID: 27497268 [TBL] [Abstract][Full Text] [Related]
5. [High-cell density cultivation of recombinant Escherichia coli for production of TRAIL by using a 2-stage feeding strategy]. Zhang Y; Shen YL; Xia XX; Sun AY; Wei DZ; Zhou JS; Zhang GJ; Wang LH; Jiao BH Sheng Wu Gong Cheng Xue Bao; 2004 May; 20(3):408-13. PubMed ID: 15971615 [TBL] [Abstract][Full Text] [Related]
6. VP1 pseudocapsids, but not a glutathione-S-transferase VP1 fusion protein, prevent polyomavirus infection in a T-cell immune deficient experimental mouse model. Vlastos A; Andreasson K; Tegerstedt K; Holländerová D; Heidari S; Forstová J; Ramqvist T; Dalianis T J Med Virol; 2003 Jun; 70(2):293-300. PubMed ID: 12696121 [TBL] [Abstract][Full Text] [Related]
7. [Hepatitis E virus capsid protein production by high cell density culture of recombinant Escherichia coli]. Liu RS; He ZQ; Li SW; Yang KY; Xian YL; Pang SQ; Zhang J; Li YM; Xia NS Sheng Wu Gong Cheng Xue Bao; 2004 May; 20(3):450-5. PubMed ID: 15971623 [TBL] [Abstract][Full Text] [Related]
8. Production and biomedical applications of virus-like particles derived from polyomaviruses. Teunissen EA; de Raad M; Mastrobattista E J Control Release; 2013 Nov; 172(1):305-321. PubMed ID: 23999392 [TBL] [Abstract][Full Text] [Related]
9. Enhanced production of human mini-proinsulin in fed-batch cultures at high cell density of Escherichia coli BL21(DE3)[pET-3aT2M2]. Shin CS; Hong MS; Bae CS; Lee J Biotechnol Prog; 1997; 13(3):249-57. PubMed ID: 9190075 [TBL] [Abstract][Full Text] [Related]
10. Encapsulation of DNA and non-viral protein changes the structure of murine polyomavirus virus-like particles. Lipin DI; Chuan YP; Lua LH; Middelberg AP Arch Virol; 2008; 153(11):2027-39. PubMed ID: 18979257 [TBL] [Abstract][Full Text] [Related]
11. Enterovirus 71 virus-like particle vaccine: improved production conditions for enhanced yield. Chung CY; Chen CY; Lin SY; Chung YC; Chiu HY; Chi WK; Lin YL; Chiang BL; Chen WJ; Hu YC Vaccine; 2010 Oct; 28(43):6951-7. PubMed ID: 20797455 [TBL] [Abstract][Full Text] [Related]
12. From shake flasks to bioreactors: survival of E. coli cells harboring pGST-hPTH through auto-induction by controlling initial content of yeast extract. Jia L; Cheng H; Wang H; Luo H; Yan H Appl Microbiol Biotechnol; 2011 May; 90(4):1419-28. PubMed ID: 21523618 [TBL] [Abstract][Full Text] [Related]
13. Generation of virus-like particles consisting of the major capsid protein VP1 of goose hemorrhagic polyomavirus and their application in serological tests. Zielonka A; Gedvilaite A; Ulrich R; Lüschow D; Sasnauskas K; Müller H; Johne R Virus Res; 2006 Sep; 120(1-2):128-37. PubMed ID: 16780983 [TBL] [Abstract][Full Text] [Related]
14. Affinity purification of viral protein having heterogeneous quaternary structure: modeling the impact of soluble aggregates on chromatographic performance. Lipin DI; Raj A; Lua LH; Middelberg AP J Chromatogr A; 2009 Jul; 1216(30):5696-708. PubMed ID: 19540501 [TBL] [Abstract][Full Text] [Related]
15. Size and position of truncations in the carboxy-terminal region of major capsid protein VP1 of hamster polyomavirus expressed in yeast determine its assembly capacity. Gedvilaite A; Aleksaite E; Staniulis J; Ulrich R; Sasnauskas K Arch Virol; 2006 Sep; 151(9):1811-25. PubMed ID: 16575481 [TBL] [Abstract][Full Text] [Related]
16. Enhanced immunogenicity of modified hepatitis B virus core particle fused with multiepitopes of foot-and-mouth disease virus. Zhang YL; Guo YJ; Wang KY; Lu K; Li K; Zhu Y; Sun SH Scand J Immunol; 2007 Apr; 65(4):320-8. PubMed ID: 17386022 [TBL] [Abstract][Full Text] [Related]
17. Production of recombinant bacteriocin divercin V41 by high cell density Escherichia coli batch and fed-batch cultures. Yildirim S; Konrad D; Calvez S; Drider D; Prévost H; Lacroix C Appl Microbiol Biotechnol; 2007 Dec; 77(3):525-31. PubMed ID: 17882416 [TBL] [Abstract][Full Text] [Related]
18. Enhanced production of recombinant streptokinase in Escherichia coli using fed-batch culture. Goyal D; Sahni G; Sahoo DK Bioresour Technol; 2009 Oct; 100(19):4468-74. PubMed ID: 19428239 [TBL] [Abstract][Full Text] [Related]
19. Oligonucleotide and plasmid DNA packaging into polyoma VP1 virus-like particles expressed in Escherichia coli. Braun H; Boller K; Löwer J; Bertling WM; Zimmer A Biotechnol Appl Biochem; 1999 Feb; 29 ( Pt 1)():31-43. PubMed ID: 9889083 [TBL] [Abstract][Full Text] [Related]
20. High yield expression in a recombinant E. coli of a codon optimized chicken anemia virus capsid protein VP1 useful for vaccine development. Lee MS; Hseu YC; Lai GH; Chang WT; Chen HJ; Huang CH; Lee MS; Wang MY; Kao JY; You BJ; Lin W; Lien YY; Lin MK Microb Cell Fact; 2011 Jul; 10():56. PubMed ID: 21781331 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]